Company / Return on Assets (ROA)
Prime Medicine, Inc. Return on Assets (ROA) History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-65.8%
FY2024
5-year range
-102.2% / -33.8%
FY2021-FY2024
Trend
+35.6%
vs FY2023
Sector context
#195 of 213
Health Care
What the data says
Among 213 Health Care companies, Prime Medicine, Inc. is in the bottom 8% for return on assets (roa). Declined from -33.8% to -65.8% over the past 2 years.
Based on SEC 10-K filings.
-65.8% in FY2024 with a 3-year CAGR of -11.1%.
Declined from -33.8% to -65.8% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -11.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 213This company -65.8% Sector average -24.1%
▼
-172.6% below sector average
Key checks
Key Insights
- In FY2024, return on assets (roa) increased 35.6% year-over-year.
- Currently 41.7pp below the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -65.8% | +35.6% |
| FY2023 | -102.2% | -202.3% |
| FY2022 | -33.8% | +38.3% |
| FY2021 | -54.8% | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026